MR-guided Radiotherapy Boost for Prostate Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University Health Network, Princess Margaret Hospital, Toronto, CanadaProstate CancerMR-guided Radiotherapy Boost - Radiation
Eligibility
18+
Male
What conditions do you have?
Select

Study Summary

This trial is testing a new treatment for prostate cancer that involves MR-guided radiotherapy. 40 patients will be recruited and monitored for up to 5 years.

Eligible Conditions
  • Prostate Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: Baseline to 5-year follow-up

Baseline
Feasibility of MR-guided Linear Acceleratorfor tumour-targeted intra-prostatic dose escalation as boost
Baseline to 5-year follow-up
Acute Toxicity
Late Toxicity
Patient-reported quality-of-life assessed by EPIC-26

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

MR-guided Tumour Boost with SBRT
1 of 1

Experimental Treatment

40 Total Participants · 1 Treatment Group

Primary Treatment: MR-guided Radiotherapy Boost · No Placebo Group · N/A

MR-guided Tumour Boost with SBRT
Radiation
Experimental Group · 1 Intervention: MR-guided Radiotherapy Boost · Intervention Types: Radiation

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to 5-year follow-up

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,386 Previous Clinical Trials
471,929 Total Patients Enrolled
62 Trials studying Prostate Cancer
15,332 Patients Enrolled for Prostate Cancer

Eligibility Criteria

Age 18+ · Male Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are scheduled to receive external beam radiation therapy (EBRT) with or without androgen deprivation therapy (ADT).

Frequently Asked Questions

Are there any opportunities to enroll in this clinical research study at present?

"Contrary to popular belief, this clinical trial is not actively accepting patients. It was first listed on January 1st 2023 and the information was last revised on October 6th 2022. Despite this fact, there are still 1321 other trials seeking participants at present time." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.